مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422Test
Trends in Pharmacological Sciences
Click here for full text options
LibKey Link

مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422Test
Trends in Pharmacological Sciences
LibKey Link

مصطلحات الفهرس: tumor necrosis factor/ec [Endogenous Compound], adult, asthma/dt [Drug Therapy], asthmatic state, atopy, blood sampling, clinical feature, corticosteroid therapy, female, forced expiratory volume, forced vital capacity, health care utilization, human, immunity, late onset disorder, letter, longitudinal study, major clinical study, male, middle aged, onset age, population research, priority journal, protein blood level, remission, seasonal variation, self report, smoking, Th1 cell, Th17 cell, Th2 cell, beta 2 adrenergic receptor stimulating agent/dt [Drug Therapy], bronchodilating agent/dt [Drug Therapy], C reactive protein/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], corticosteroid/ih [Inhalational Drug Administration], corticosteroid/po [Oral Drug Administration], cytokine/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 12/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 5/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], interleukin 8/ec [Endogenous Compound], long acting drug/dt [Drug Therapy], Letter

URL: Allergy: European Journal of Allergy and Clinical Immunology
Click here for full text options
LibKey Link

مصطلحات الفهرس: toll like receptor 4/ec [Endogenous Compound], toll like receptor 5/ec [Endogenous Compound], toll like receptor 6/ec [Endogenous Compound], toll like receptor 7/ec [Endogenous Compound], toll like receptor 8/ec [Endogenous Compound], toll like receptor 9/ec [Endogenous Compound], transcription factor GATA 3/ec [Endogenous Compound], transcription factor T bet/ec [Endogenous Compound], transforming growth factor beta/ec [Endogenous Compound], toll like receptor 11/ec [Endogenous Compound], adult, animal cell, animal experiment, animal model, article, controlled study, human, human tissue, immunology, infant, innate immunity, intestine injury, low birth weight, lymphoid cell, male, microbial diversity, monocyte, mortality rate, mouse, necrotizing enterocolitis/et [Etiology], newborn, nonhuman, pneumatosis intestinalis, prematurity, Th17 cell, CXCL1 chemokine/ec [Endogenous Compound], interleukin 1 receptor/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 17F/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 21/ec [Endogenous Compound], interleukin 22/ec [Endogenous Compound], interleukin 23/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], natural cytotoxicity triggering receptor 1/ec [Endogenous Compound], retinoid related orphan receptor gamma/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], toll like receptor 10/ec [Endogenous Compound], toll like receptor 2/ec [Endogenous Compound], toll like receptor 3/ec [Endogenous Compound], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28976Test
Nature Communications
LibKey Link

مصطلحات الفهرس: tumor necrosis factor/ec [Endogenous Compound], adult, asthma/dt [Drug Therapy], asthmatic state, atopy, blood sampling, clinical feature, corticosteroid therapy, female, forced expiratory volume, forced vital capacity, health care utilization, human, immunity, late onset disorder, letter, longitudinal study, major clinical study, male, middle aged, onset age, population research, priority journal, protein blood level, remission, seasonal variation, self report, smoking, Th1 cell, Th17 cell, Th2 cell, beta 2 adrenergic receptor stimulating agent/dt [Drug Therapy], bronchodilating agent/dt [Drug Therapy], C reactive protein/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], corticosteroid/ih [Inhalational Drug Administration], corticosteroid/po [Oral Drug Administration], cytokine/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 12/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 5/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], interleukin 8/ec [Endogenous Compound], long acting drug/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29014Test
Allergy: European Journal of Allergy and Clinical Immunology
LibKey Link

مصطلحات الفهرس: recombinant human interleukin 2/sc [Subcutaneous Drug Administration], recombinant human interleukin 2/dt [Drug Therapy], injection site reaction/si [Side Effect], low drug dose, male, mouse, multiple cycle treatment, nonhuman, open study, priority journal, prospective study, regulatory T lymphocyte, single drug dose, SLEDAI, systemic lupus erythematosus/dt [Drug Therapy], T lymphocyte subpopulation, Th17 cell, Th2 cell, adult, aged, animal experiment, animal model, article, CD4+ T lymphocyte, clinical article, controlled study, cytokine production, drug dose reduction, drug withdrawal, female, flu like syndrome/si [Side Effect], human, infection/si [Side Effect], treatment response, aldesleukin/cm [Drug Comparison], interleukin 17, prednisone, recombinant interleukin 2/ae [Adverse Drug Reaction], recombinant interleukin 2/cm [Drug Comparison], recombinant interleukin 2/dt [Drug Therapy], recombinant interleukin 2/sc [Subcutaneous Drug Administration], unclassified drug, recombinant human interleukin 2/ae [Adverse Drug Reaction], recombinant human interleukin 2/cm [Drug Comparison], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39847Test
Nature Medicine
Click here for full text options
LibKey Link

مصطلحات الفهرس: treatment duration, glucocorticoid, interleukin 17/ec [Endogenous Compound], leucine zipper protein/ec [Endogenous Compound], unclassified drug, glucocorticoid induced leucine zipper protein/ec [Endogenous Compound], drug use, autoimmune disease, corticosteroid therapy, disease activity, disease association, health care cost, human, nonhuman, priority journal, protein expression, psoriasis, review, rheumatoid arthritis, Th1 cell, Th17 cell, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39616Test
Nature Reviews Rheumatology
Click here for full text options
LibKey Link

مصطلحات الفهرس: recombinant human interleukin 2/sc [Subcutaneous Drug Administration], recombinant human interleukin 2/dt [Drug Therapy], injection site reaction/si [Side Effect], low drug dose, male, mouse, multiple cycle treatment, nonhuman, open study, priority journal, prospective study, regulatory T lymphocyte, single drug dose, SLEDAI, systemic lupus erythematosus/dt [Drug Therapy], T lymphocyte subpopulation, Th17 cell, Th2 cell, adult, aged, animal experiment, animal model, article, CD4+ T lymphocyte, clinical article, controlled study, cytokine production, drug dose reduction, drug withdrawal, female, flu like syndrome/si [Side Effect], human, infection/si [Side Effect], treatment response, aldesleukin/cm [Drug Comparison], interleukin 17, prednisone, recombinant interleukin 2/ae [Adverse Drug Reaction], recombinant interleukin 2/cm [Drug Comparison], recombinant interleukin 2/dt [Drug Therapy], recombinant interleukin 2/sc [Subcutaneous Drug Administration], unclassified drug, recombinant human interleukin 2/ae [Adverse Drug Reaction], recombinant human interleukin 2/cm [Drug Comparison], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39847Test
Nature Medicine
LibKey Link

مصطلحات الفهرس: treatment duration, glucocorticoid, interleukin 17/ec [Endogenous Compound], leucine zipper protein/ec [Endogenous Compound], unclassified drug, glucocorticoid induced leucine zipper protein/ec [Endogenous Compound], drug use, autoimmune disease, corticosteroid therapy, disease activity, disease association, health care cost, human, nonhuman, priority journal, protein expression, psoriasis, review, rheumatoid arthritis, Th1 cell, Th17 cell, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39616Test
Nature Reviews Rheumatology
LibKey Link

مصطلحات الفهرس: interleukin 5 antibody/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], nephritogenic antigen/ec [Endogenous Compound], retinoid related orphan receptor gamma/ec [Endogenous Compound], STAT6 protein/ec [Endogenous Compound], transcription factor T bet/ec [Endogenous Compound], rapidly progressive glomerulonephritis, animal cell, animal tissue, article, cell function, controlled study, cytokine production, histology, immune response, kidney injury, male, mouse, nonhuman, priority journal, protein function, Th1 cell, Th17 cell, wild type, immunoglobulin antibody, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30340Test
Click here for full text options
LibKey Link